Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
Filters
3
NCT01480479
2018-01-16
ACT IV
Celldex Therapeutics
Phase 3
Completed
745 enrolled
NCT00091676
2012-02-03
BiovaxID
Biovest International
Phase 3
Unknown
629 enrolled